. 2016 Dec 27;8(12):18935–18942. doi: 10.18632/oncotarget.14277

Table 1. Lung W/D ratio and SPA, IL-6 and TNF-α levels in plasma (n = 8).

Group	W/D	plasma
Group	W/D	SPA(ng/L)	TNF-a (μg/L)	IL-18 (μg/L)
Control Group	3.69 ± 1.12	16.01 ± 1.33	38.02 ± 8.35	32.22 ± 3.71
GLA	3.82 ± 2.01	16.41 ± 2.01	36.76 ± 6.72	31.42 ± 3.18
LPS
6 h	5.55 ± 0.73^a	18.13 ± 2.53	106.26 ± 30.37^a	49.21 ± 6.35^a
12 h	5.82 ± 0.94^a	22.3 ± 2.79^a	105.91 ± 28.29^a	49.37 ± 13.27^a
24 h	5.63 ± 0.47^a	20.63 ± 3.67 ^a	93.04 ± 21.66^a	42.34 ± 14.01^a
LPS+GLA
6 h	4.31 ± 1.79^b	16.81 ± 3.34	58.24 ± 19.86^b	36.35 ± 27.94^b
12 h	4.30 ± 0.67^{b a}	18.82 ± 1.88^b	50.67 ± 9.42^b	36.82 ± 12.56^b
24 h	4.25 ± 0.96^a	18.43 ± 1.66^b	61.50 ± 21.82^b	39.36 ± 8.29^b

The table indicates the change of W/D, SPA, IL-18, TNF-a among the groups, compared with control group ^aP < 0.05, and compare with LPS group ^bP < 0.05.